Provisions that would overhaul the US Food and Drug Administration’s oversight of the cosmetics industry have made the cut in an omnibus bill to fund the government in 2023, moving the long-awaited reforms tantalizingly close to the finish line.
Released 20 December, the Consolidated Appropriations Act of 2023 is a massive, sprawling spending bill that directs $1.7 trillion in fiscal dollars for next year
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?